BJDX Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-3.740.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$5.0MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
1.19
P/S (TTM)
54.99
EV/EBITDA
-0.10

Profitability & growth

ROE (TTM)
-171.6%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
0.82
Last earnings
May 29, 2026 · Reported $-1.95
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Bluejay Diagnostics Inc

Bluejay Diagnostics Inc. is a forward-thinking medical technology company dedicated to transforming patient care through its innovative diagnostic solutions, emphasizing early disease detection. The firm employs a proprietary platform that integrates advanced artificial intelligence with point-of-care testing to enhance diagnostic accuracy and expedite results, empowering healthcare providers with crucial insights in real-time. With a strong commitment to research and development, Bluejay is strategically positioned to address significant healthcare challenges and meet the increasing demand…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
360 MASSACHUSETTS AVENUE, ACTON, MA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$5.0M
Shares outstanding$1.0M
52W high$16.68
52W low$1.62

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer